CACNA1C nucleic acid mutations as indicators of shorter than...

Details CACNA1C nucleic acid mutations as indicators of shorter than... CACNA1C nucleic acid mutations as indicators of shorter than...

2007-11-06

2010-11-16

Saoud, Christine J (Department: 1647)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S091200, C536S023500, C536S024310, C530S350000

Reexamination Certificate

active

07833718

ABSTRACT:
Previously unknown mutations of the CACNA1C and CACNB2b genes are disclosed which are involved in ion channel disruptions associated with shorter than normal QT interval and ST segment elevation syndrome. These mutations are utilized to diagnose and screen for shorter than normal QT interval and ST segment elevation syndrome, thus providing modalities for diagnosing syncope and/or sudden cardiac death and/or predicting susceptibility to syncope and/or sudden cardiac death. Nucleic acid probes are provided which selectively hybridize to the mutant nucleic acids described herein. Antibodies are provided which selectively bind to the mutant polypeptides described herein. The mutations described herein are also utilized to screen for compounds useful in treating the symptoms manifest by such mutations.

REFERENCES:
patent: 5599673 (1997-02-01), Keating et al.
patent: 6207383 (2001-03-01), Keating et al.
patent: 6274332 (2001-08-01), Keating et al.
patent: 6277978 (2001-08-01), Keating et al.
patent: 6420124 (2002-07-01), Keating et al.
patent: 6432644 (2002-08-01), Keating et al.
patent: 6451534 (2002-09-01), Keating et al.
patent: 6458542 (2002-10-01), George, Jr. et al.
patent: 6582913 (2003-06-01), Keating et al.
patent: 2005/0130190 (2005-06-01), Antzelevitch et al.
Splawski et al, Cav 1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism, Cell, Oct. 1, 2004, pp. 19-31, vol. 119.
Splawski et al., Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations, PNAS, Jun. 7, 2005, pp. 8089-8096, vol. 102.
Schott et al., Cardiac conduction defects associate with mutations in SCN5A, Nature Genetics, vol. 23, Sep. 1999, pp. 20-21, vol. 23.
Priori et al., A Novel Form of Short QT Syndrome (SQT3) is Caused by a Mutation in the KCNJ2 Gene, Circulation Research, Apr. 15, 2005, pp. 800-807.
Fish et al., Role of Sodium and Calcium Channel Block in Unmasking the Brugada Syndrome, Heart Rhythm (2004) 1, 210-217.
Antzelevitch, et al., Brugada Syndrome, Report of the Second Consensus Conference, Circulation, Feb. 8, 2005, pp. 659-670.
Extramiana, et al., Amplified Transmural Dispersion of Repolarization as the Basis for Arrhythmogenesis in a Canine Ventricular-Wedge Model of Short-QT Syndrome, Cellular Basis of Short-QT Syndrome, Cell, Dec. 14, 2004, pp. 3661-3666.
Brugada et al., Sudden Death Associated With Short-QT Syndrome Linked to Mutations In HERG, Genetic and Biophysical Basis for Short-QT Syndrome, Circulation, Jan. 6/13, 2004, pp. 30-35.
Bellocq et al., Mutation in the KCNQ1 Gene Leading to the Short QT-Interval Syndrome, KCNQ1 Mutation in Short QT-Interval Syndrome, Circulation, May 25, 2004, pp. 2394-2397.

Affiliated with

Also associated with

Rating

CACNA1C nucleic acid mutations as indicators of shorter than... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CACNA1C nucleic acid mutations as indicators of shorter than..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CACNA1C nucleic acid mutations as indicators of shorter than... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4193317